Concurrent aortic stenosis and hypertension: mortality trends in US older adults from 1999–2020
Open Access
- 21 July 2025
- journal article
- Published by Taylor & Francis in Future Cardiology
- Vol. 21 (10) , 769-778
Abstract
Aortic Stenosis (AS) is a valvular heart disease. Hypertension accelerates stenosis, increasing morbidity and mortality. This study investigates mortality trends in US older adults with AS and hypertension from 1999 to 2020. Using the CDC WONDER database, age-adjusted mortality rates (AAMRs) per 100,000 individuals aged 65+ with AS and hypertension were analyzed. Changes in AAMRs were examined through annual percent change (APC) and average APC (AAPC) using Joinpoint regression. From 1999 to 2020, hypertension caused 99,250 deaths in AS patients in the US, demonstrating an increasing trend (AAPC: 5.51%). Males had higher AAMRs (11.51) than females (9.99). Non-Hispanic (NH) white people (11.32) had the highest AAMRs, followed by Hispanic (7.37), NH Black people (7.27), and NH Asians (6.12). Regionally, the West showed the highest AAMR (13.3), followed by the Midwest (11.38), the Northeast (10.62), and the South (8.53). The states with the highest AAMRs were Vermont and Oregon, while Alabama and Georgia had the lowest. Non-metropolitan areas (11.19) experienced higher mortality than metropolitan areas (10.49). We report increasing mortality rates in patients with AS and hypertension, especially in males, NH white people, and the West. Target healthcare measures are needed to address the rising mortality.Keywords
This publication has 44 references indexed in Scilit:
- Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic StenosisJACC: Cardiovascular Interventions, 2025
- Diagnostic Category Prevalence in 3 Classification Systems Across the Transition to the International Classification of Diseases, Tenth Revision, Clinical ModificationJAMA Network Open, 2020
- Racial and Ethnic Differences in Treatment and Outcomes of Severe Aortic StenosisJACC: Cardiovascular Interventions, 2020
- Racial Disparities in the Utilization and Outcomes of TAVRJACC: Cardiovascular Interventions, 2019
- Association of Primary Care Physician Supply With Population Mortality in the United States, 2005-2015JAMA Internal Medicine, 2019
- Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve ReplacementJAMA, 2018
- Sex, Race, and Socioeconomic Disparities in Patients With Aortic Stenosis (from a Nationwide Inpatient Sample)The American Journal of Cardiology, 2016
- Beta-blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosisInternational Journal of Cardiology, 2015
- The Prevalence, Incidence, Progression, and Risks of Aortic Valve SclerosisJACC, 2014
- Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: symptomatic cardiac obstruction–pilot study of enalapril in aortic stenosis (SCOPE-AS)American Heart Journal, 2004